Doxycycline (OncoSynergy)

多西环素(OncoSynergy)

Report date: 2026/03/04 20:01:44

Base Information

Drug NameDoxycycline (OncoSynergy)
Drug Alias Name强力霉素OS-342NX-101
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Tetracycline antibiotics
Mechanisms of Action30S ribosomal subunit inhibitorsMatrix metalloproteinase inhibitors
Targets30S ribosomal subunitMatrix metalloproteinase
Therapy Area/IndicationsNeurofibromatoses
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesRenovaro Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRenovaro Biosciences Inc
Active IndicationsN/A
Inactive IndicationsNeurofibromatoses

Other Information

ATC CodeN/A
Related LinksN/A